During the past decade, Oncology Consultants conducted 76 clinical trials. In the 10-year time frame, 76 clinical trials started and 33 clinical trials were completed, i.e. on average, 43.4% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 23 clinical trials were completed. i.e. 60.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology Consultants" #1 sponsor was "Novartis Pharmaceuticals" with 16 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 5 trials sponsored, "Gilead Sciences" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Consultants" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "CIRION Central Laboratory" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Consultants" are "Breast Cancer" (11 trials), "Non-Small Cell Lung Cancer" (5 trials), "Pancreatic Cancer" (5 trials), "Solid Tumors" (5 trials) and "Advanced Solid Tumor" (4 trials). Many other conditions were trialed in "Oncology Consultants" in a lesser frequency.

Most popular intervention types in "Oncology Consultants" are "Drug" (99 trials), "Biological" (9 trials), "Device" (2 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (9 trials), "Gemcitabine" (8 trials), "Placebo" (8 trials), "Pembrolizumab" (7 trials) and "Pemetrexed" (7 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Consultants" are 95 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Oncology Consultants". undefined are not yet recruiting, 25 are recruiting, 18 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 41 completed trials in Oncology Consultants, 1 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Consultants, 25 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".

Oncology Consultants has several departments that took part in Clinical trials: "Oncology Consultants,925 Gessner" - 2 trials